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Dithranol is well known to dermatologists: during 
antipsoriatic therapy with dithranol, a brownish stain-
ing frequently occurs in the lesions as well as the 
surrounding non-involved skin, and there have been 
various efforts [5] to eliminate or to diminish this side 
effect. The present study is concerned with dithranol 
brown located in the brown psoriatic scales obtained 
from patients undergoing dithranol therapy (dithranol 
with 2% salicylic acid in white soft paraffin). 
Microscopic examination showed that dithranol 
brown is deposited in the form of well-defined 
brownish particles in the stratum corneum. These 
particles were isolated using a micromanipulator and 
introduced into a 311A mass spectrometer via a heated 
inlet system (90° C, 120° C). High resolution revealed 
the presence of hydrocarbons [ C 1 8 H 3 6 , C 2 8 ^ 5 ^ L 
C27H44 (cholestadiene)] and an oxygenated steroid 
C 2 7 H 4 6 0 (cholestenol or cholestanone). When the in-
let system of a CH5 mass spectrometer was heated to 
450° C, we obtained a very weak signal at m/z = 446 
from a dimethylsulfoxide (DMSO) extract of brown 
scales, which might be attributable to tetrahydroxy-
helianthrone [2]; under these conditions, however, the 
formation of artifacts cannot be excluded. 
The proteolytic degradation of brown scales using 
Pronase followed by CHC1 3 extraction revealed the 
molecular ions of dithranol, chrysazine and 1,8,1',8'-
tetrahydroxybisanthrone (m/z = 450; <1%), and the 
corresponding fragment ions (Fig. 1). 
The excitation of a single brown particle to an 
ionized state under microscopic control using a 
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Fig. 1. Formulas of dithranol (7), chrysazine (2) and 1,8,l',8'-
tetrahydroxybisanthrone (3) 
focused laser beam ( L A M M A [3]) indicated the pre-
sence of copper (m/z = 63 and m/z = 65; intensity 
relation approximately 2:1); under identical con-
ditions, no copper was found in the surrounding light-
coloured area. The application of L A M M A to scales 
from psoriatic lesions which had been treated with 
dithranol revealed the presence of negative ions at 
240 mu (chrysazine) and 225 mu [either (M-l)~ of 
dithranol or a fragment ion of l,8,r,8'-tetrahydroxy-
bisanthrone; bisbenzylic cleavage]. The validation of 
these results with dithranol, chrysazine and the bis-
anthrone indicated m/z = 225 for dithranol, [(M-H)"] 
and for the bisanthrone (fragmentation of the bis-
benzylic bond), while chrysazine produced M ' ~ at 
m/z = 240, followed by loss of 29 mu (HCO) to 
m/z = 211 (Fig. 2) [6]. 
When we heated brown scales to 300° C in a TAS 
apparatus (DESAGA, Heidelberg, FRG), we 
obtained a yellow sublimate which contained 
chrysazine. Van Duuren et al. [8] have prepared 
complexes of chrysazine with various metals including 
copper. Although copper and chrysazine are found in 
the same compartment, the identity of Van Duuren's 
complex and dithranol brown cannot be deduced from 
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Fig. 2. L A M M A of chrysazine: loss of H C O ' 
Table 1. Penetration und metabolization of 1% dithranol in 
white soft paraffin in psoriatic patients in vivo. Separation of 
the skin by suction blister technique 
Penetration Epidermis Blister Dermis 
time [min] fluid 
Psoriatic 60 1: + 2: + Negative 
lesion 2: + + + 
3: + + 
Uninvolved 285 2: + 2: + 2: + 
skin 
this experiment. We were unable to isolate this 
complex or any similar copper complex from the 
brown scales; Van Duuren's statement about the 
solubility and ligand exchange of his complex explains 
this failure. Our results, however, pointed towards 
a metabolization of dithranol to chrysazine in the 
epidermis. This proved to be true: after being treated 
with dithranol in white soft paraffin, the epidermis 
and dermis of the involved and uninvolved skin of 
psoriatic patients were separated by suction blisters 
[4]. The epidermis, the blister fluid and the upper part 
of the dermis were analysed (Table 1). 
Although Sa e Melo et al. [7] using gas chromatog-
raphy mass spectrometry (GC-MS) after the topical 
application of dithranol to normal human skin did not 
detect dithranol or its metabolites as silylized 
derivatives in suction-blister fluid, our results indicate 
that chrysazine and l,8,r,8'-tetrahydroxybisanthrone 
occur in the blister tissues of psoriatic skin. Although 
unlikely, the contribution of melanin to the discolour-
ation was considered, because tyrosinase (polyphenol 
oxidase) is a Cu-protein. This consideration was 
experimentally cancelled: the hypomelanotic areas of 
vitiligo patients are stained by dithranol. 
Experiments 
1. Isolation of Brown Particles from Scales 
Brown particles were excised out of brown scales using 
a micromanipulator under microscopic control. 
Brown particles (0.1 mg) were extracted with DMSO 
in a Soxhlet apparatus, the solvent was evaporated in 
Table 2. High resolution measurements 
m/z Formula Calculated Found 
252 C i 8 H 3 6 252.28169 252.28118 
368 C27H44 368.34429 368.34443 
386 C 2 8 H 5 0 (65%) 386.39123 386.39013 
386 C 2 7 H 4 6 O (35%) 386.35485 386.35470 
vacuo and the residue was analysed by mass 
spectrometry. 
Brown scales (15 mg) were degraded with 10 mg 
Pronase (Boehringer) in 10 ml Tris buffer for 2 h at 
25° C. The mixture was extracted three times with 
10 ml CHCI3, and the organic solution was dried 
(Na 2 S0 4 ), evaporated in vacuo and analysed by thin 
layer chromatography (tic) (Al sheets, silica 60 F 2 5 4 > 
toluene/glacial acetic acid 80/20 v/v) and mass spec-
trometry. The high-resolution measurements (311 A) 
of the extract are given in Table 2. 
2. Electron-Impact (EI) Mass Spectrometry 
The mass spectra of dithranol, chrysazine and 
l^r^'-tetrahydroxybisanthrone (CH 5) are as fol-
lows: 
1. Dithranol: 12eV: m/z = 226 (M + \ 100%); 
70eV: m/z = 226 (100%), 198 ( M + - C O , 22%), 181 
(8%) 
2. Chrysazine: 12eV: m/z = 240 (M + \ 100%); 
70eV: m/z = 240 (100%), 212 (M + ' - C O ; 14%; m* 
= 187.27), 184(212-CO; 10%, m* = 159.70) 
3. l,8,r,8'-tetrahydroxybisanthrone: 11 eV: m/z 
= 450 (M + \ <1%), 225 (100%); 70eV: m/z = 225 
(100%), 197 (225-CO; 48%) 
3. Laser Microprobe Mass Analyser (LAMMA) 
Experiments 
Al l measurements with ALaser = 265 nm; T L a s e r = 10 ns. 
The positive mass spectra of the brown particle re-
vealed m/z = 63 + (Cu, 100%) and 65 + (Cu, 50%). 
The negative mass spectra of dithranol indicated 
m/z = 225 [(M-H)", 100%]. One day after prepara-
tion, the pertinent spectra showed: m/z = 225 
[(M-H)", 100%], 240 (chrysazine"*, 43%) and 211 
(5.5%). Under identical conditions, chrysazine led to 
fragments at: m/z = 240 ( M - * , 100%) and 211 
[ ( M - H C O y , 80%] while l,8,l',8'-tetrahydroxybis-
anthrone was cleaved to m/z = 225 (M/2", 100%). 
4. Preparation of the Chrysazine-Cu Complex 
This was performed according to the method of Van 
Duuren et al. [8]. 
5. Pyrolysis of Brown Scales in a TAS Apparatus 
About 10 mg brown scales were cut into pieces, placed 
in the glass tube of a TAS apparatus and heated to 
150°, 200°, 250°, 300° and 350° C. 
6. Analysis of Blister Tissue 
Highly refined 1% dithranol [1] in white soft paraffin 
was applied to both the uninvolved skin and lesions 
of psoriatic patients in vivo; after defined periods, it 
was removed by washing with a hydrophile lipogel 
(Table 1). The epidermis and dermis were separated 
using the suction-blister technique [4], and the tissue 
samples were stored at - 2 5 ° C . Histologically iden-
tical samples were combined in batches of 2 —30 mg 
and extracted with 5 ml acetone under N 2 at room 
temperature. The solvent was evaporated in a N 2 
stream, and the residue was dissolved in 0.50 ml 
acetone; 10 \i\ of this solution were used for tic. 
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